Ly6k Antikörper (N-Term)

Produktnummer ABIN1450086

Produktdetails anti-Ly6k Antikörper

Target: Ly6k (Lymphocyte Antigen 6 Complex, Locus K (Ly6k))

Bindungsspezifität: N-Term

Reaktivität: Human, Maus, Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser Ly6k Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Enzyme Immunoassay (EIA)

Aufreinigung: Affinity chromatography purified via peptide column

Immunogen: Rabbit polyclonal LY6K antibody was raised against an 18 amino acid synthetic peptide near the amino terminus of Human LY6K

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 1.0 mg/mL

Buffer: PBS containing 0.02 % Sodium Azide as preservative

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid repeated freezing and thawing.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Details zu Ly6k

Target: Ly6k (Lymphocyte Antigen 6 Complex, Locus K (Ly6k))

Andere Bezeichnung: LY6K (Ly6k Produkte)

Synonyme: LY6K antikoerper, CT97 antikoerper, HSJ001348 antikoerper, ly-6K antikoerper, 2410015A16Rik antikoerper, 3110035B01Rik antikoerper, mLy-6K antikoerper, lymphocyte antigen 6 family member K antikoerper, lymphocyte antigen 6 complex, locus K antikoerper, LY6K antikoerper, Ly6k antikoerper

Hintergrund: The lymphocyte antigen 6 complex locus K (LY6K), a member of cancer-testis antigen was initially identified as a molecular marker for head-and-neck squamous cell carcinoma as well a breast cancer. LY6K is a GPI-anchored membrane protein that is specifically associated with germ cell marker TEX101 and is strongly observed in testis, but only weakly in other tissues. LY6K mRNA was found to be upregulated in numerous bladder cancers due to gene amplification. Furthermore, knockdown experiments using LY6K siRNA reduced cell growth, migration and invasion in bladder carcinoma cell lines, suggesting that LY6K contributes to bladder cancer development.Synonyms: CO16, Ly-6K, Lymphocyte antigen 6K

Gen-ID: 54742